Re: A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy-Adjuvant versus Early Salvage (RAVES) trial.

S. Taneja
DOI: https://doi.org/10.1016/j.juro.2014.11.067
2015-02-01
Abstract:
What problem does this paper attempt to address?